Reduced Relapse Rate in Upfront Tandem Autologous/Reduced-Intensity Allogeneic Transplantation in Multiple Myeloma Only Results in Borderline Non-Significant Prolongation of Progression-Free but Not Overall Survival

Haematologica - Italy
doi 10.3324/haematol.2015.128728
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

GvHD-free, Relapse-Free Survival After Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Myeloid Malignancies

Bone Marrow Transplantation
TransplantationHematology
2016English

Reduced Progression-Free Survival in Elderly Patients Receiving Intensification With Autologous Peripheral Blood Stem Cell Reinfusion for Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
1998English

The Current Status of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients With Advanced Indolent B Cell Malignancies: CALGB 109901

Biology of Blood and Marrow Transplantation
TransplantationHematology
2011English

Autologous Transplantation Followed Closely by Reduced-Intensity Allogeneic Transplantation as Consolidative Immunotherapy in Advanced Lymphoma Patients: A Feasibility Study

Bone Marrow Transplantation
TransplantationHematology
2005English

Validation of a New Integrated Prognostic Score to Predict Non-Relapse Mortality in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2015English

Impact of MiRSNPs on Survival and Progression in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Clinical Cancer Research
Cancer ResearchOncology
2012English

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Impact of Donor Gender on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Reduced Relapse Risk in Female to Male Transplants

Bone Marrow Transplantation
TransplantationHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy